Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Hyperthermia × Breast × Clear all

Phase

Phase NA 3 Phase 3 1 Phase 2/3 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Gastrointestinal 1 Breast 1

Conditions

Breast Neoplasms 102 Triple Negative Breast Neoplasms 8 Neoplasms 4 Neoplasm Metastasis 4 HER2-positive Breast Cancer 4 Prostatic Neoplasms 3 Motor Activity 3 Inflammatory Breast Neoplasms 3 Depression 3 Lung Neoplasms 2 Fatigue 2 Colorectal Neoplasms 2 Carcinoma, Ductal, Breast 2 Breast Diseases 2 Breast Carcinoma In Situ 2 Anxiety Disorders 2 Urinary Incontinence 1 To Evaluate the Effectiveness of GM1 in the Prevention of Albumin-paclitaxel Therapy Induced Peripheral Neuropathy in Breast Cancer Patients 1 Smoking 1 Sleepiness 1 Sarcoma 1 Recurrence 1 Radiodermatitis 1 Radiation Injuries 1 Peripheral Nervous System Diseases 1 Parasomnias 1 Pain 1 Ovarian Neoplasms 1 Orgasm 1 Obesity 1

Interventions

Paclitaxel 1 Carboplatin 1 AC protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05889390 2024-12-03

NeoHTerMa

Semmelweis University

Phase 2/3 Active not recruiting

Hyperthermia, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡